Vinclozolin is a fungicide whose metabolites are androgen receptor (AR) ant
agonists. Previous work in our laboratory showed that perinatal administrat
ion of vinclozolin to rats results in malformations of the external genital
ia, permanent nipples, reduced anogenital distance (AGD), and reduced semin
al vesicle, ventral prostate, and epididymal weights. The objectives of thi
s study were to determine the most sensitive period of fetal development to
antiandrogenic effects of vinclozolin and to identify a dosing regime that
would induce malformations in all of the male offspring. Pregnant rats wer
e dosed with 400 mg vinclozolin/kg/day on either GD 12-13, GD 14-15, GD 16-
17, GD 18-19, or GD 20-21, or with corn oil (2.5 ml/kg) from GD 12 through
GD 21 (Experiment 1). All 2-day periods in which significant effects were p
roduced were included in an extended dosing period, GD 14 through GD 19, in
which pregnant rats were dosed with 200 or 400 mg vinclozolin/kg (Experime
nt 2). In Experiment 1, significant effects of vinclozolin were observed in
rats dosed on gestation days (GD) 14-15, GD 16-17, and GD 18-19, while the
most significant effects were observed in rats treated on GD 16-17. These
effects include reduced AGD; presence of areolas, nipples, and malformation
s of the phallus; and reduced levator ani/bulbocavernosus weight. In contra
st, ventral prostate weight was reduced only in the GD 18-19 group. The exp
anded dosing regime (Experiment 2) increased the percentage of male offspri
ng with genital malformations (> 92%), and retained nipples (100%), further
reduced the weight of the ventral prostate, and reduced the weight of the
seminal vesicles. In addition, malformations were more severe and included
vaginal pouch and ectopic/undescended testes. The latter was induced only i
n the 400 mg/kg group. These data indicate that the reproductive system of
the fetal male rat is most sensitive to antiandrogenic effects of vinclozol
in on GD 16 and 17, although effects are more severe and 100% of male offsp
ring are affected with administration of vinclozolin from GD 14 through GD
19.